Farideh Z. Bischoff, Ph.D. is a seasoned expert in reproductive genetics and cancer biology, currently serving as Chief Medical Officer at Heranova Lifesciences. With over 30 years of experience, she has led clinical assay development, translational research, and scientific collaborations across academia and biotech globally. Dr. Bischoff holds a Ph.D. in Cancer Biology and completed postdoctoral training at M.D. Anderson Cancer Center. Her work has advanced non-invasive diagnostics in oncology and prenatal medicine.  Her current efforts are focused on advancing noninvasive diagnostics in women’s health, including endometriosis.